Clusterin in Alzheimer’s disease: an amyloidogenic inhibitor of amyloid formation.

Spatharas PM, Nasi GI, Tsiolaki PL, Theodoropoulou MK, Papandreou NC, Hoenger A, Trougakos IP, Iconomidou VA

bioRxiv, 2021

doi:10.1101/2021.04.02.438207.

Al amyloidosis with cardiac involvement: cardiotoxicity of aggregation prone peptides deriving from variable domains of immunoglobulin light chains.

Nikolaou P, Nasi G, Sulaiman I, Spatharas P, Kikionis S, Efentakis P, Ioannou E, Roussis V, Davidson S, Terpos E, Dimopoulos M, Kastritis E, Iconomidou V, Andreadou I

European Heart Journal, 2020

doi:10.1093/ehjci/ehaa946.0886.